Cargando…
Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging
OBJECTIVE: Visually estimated coronary artery calcium (VECAC) from chest CT or attenuation correction (AC)/CT obtained during positron emission tomography (PET)–myocardial perfusion imaging (MPI) is feasible. Our aim was to determine the prognostic value of VECAC beyond conventional risk factors and...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108688/ https://www.ncbi.nlm.nih.gov/pubmed/33963079 http://dx.doi.org/10.1136/openhrt-2021-001648 |
_version_ | 1783690165367078912 |
---|---|
author | Selvaraj, Senthil Khan, Muhammad Shoaib Vidula, Mahesh K Wiener, Philip C de Feria, Alejandro E Rojulpote, Chaitanya Krishnan, Sheela Tamrat, Ruth Julien, Howard Jacoby, Douglas Litt, Harold Pryma, Daniel Dubroff, Jacob Guerraty, Marie A Bravo, Paco |
author_facet | Selvaraj, Senthil Khan, Muhammad Shoaib Vidula, Mahesh K Wiener, Philip C de Feria, Alejandro E Rojulpote, Chaitanya Krishnan, Sheela Tamrat, Ruth Julien, Howard Jacoby, Douglas Litt, Harold Pryma, Daniel Dubroff, Jacob Guerraty, Marie A Bravo, Paco |
author_sort | Selvaraj, Senthil |
collection | PubMed |
description | OBJECTIVE: Visually estimated coronary artery calcium (VECAC) from chest CT or attenuation correction (AC)/CT obtained during positron emission tomography (PET)–myocardial perfusion imaging (MPI) is feasible. Our aim was to determine the prognostic value of VECAC beyond conventional risk factors and PET imaging parameters, including coronary flow reserve (CFR). METHODS: We analysed 608 patients without known coronary artery disease who underwent PET–MPI between 2012 and 2016 and had AC/CT and/or chest CT images. We used Cox regression to estimate the association of VECAC categories (≤10, 11–400, >400 Agatston units (AU)) with the primary outcome of all-cause death, acute coronary syndrome or stroke (mean follow-up 4.3±1.8 years). C-statistics assessed the relationship between PET parameters and VECAC with the primary outcome. RESULTS: Mean age was 58±11 years, 65% were women and 67% were black. VECAC ≤10, 11–400 and >400 AU was observed in 68%, 12% and 20% of subjects, respectively. Compared with VECAC ≤10, VECAC categories 11–400 (HR 2.25, 95% CI 1.24 to 4.08) and >400 AU (HR 3.05, 95% CI 1.87 to 4.98) were associated with the primary outcome after adjusting for traditional risk factors, MPI findings and CFR. Adding VECAC to a model that included PET–MPI, CFR and clinical risk factors improved the prognostic value for the primary outcomes (c-statistic 0.71 to 0.75 with VECAC, p=0.01). CONCLUSIONS: VECAC is a potent predictor of events beyond traditional risk factors and PET imaging markers, including CFR. These data further support the importance for routine VECAC implementation. |
format | Online Article Text |
id | pubmed-8108688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-81086882021-05-24 Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging Selvaraj, Senthil Khan, Muhammad Shoaib Vidula, Mahesh K Wiener, Philip C de Feria, Alejandro E Rojulpote, Chaitanya Krishnan, Sheela Tamrat, Ruth Julien, Howard Jacoby, Douglas Litt, Harold Pryma, Daniel Dubroff, Jacob Guerraty, Marie A Bravo, Paco Open Heart Cardiac Risk Factors and Prevention OBJECTIVE: Visually estimated coronary artery calcium (VECAC) from chest CT or attenuation correction (AC)/CT obtained during positron emission tomography (PET)–myocardial perfusion imaging (MPI) is feasible. Our aim was to determine the prognostic value of VECAC beyond conventional risk factors and PET imaging parameters, including coronary flow reserve (CFR). METHODS: We analysed 608 patients without known coronary artery disease who underwent PET–MPI between 2012 and 2016 and had AC/CT and/or chest CT images. We used Cox regression to estimate the association of VECAC categories (≤10, 11–400, >400 Agatston units (AU)) with the primary outcome of all-cause death, acute coronary syndrome or stroke (mean follow-up 4.3±1.8 years). C-statistics assessed the relationship between PET parameters and VECAC with the primary outcome. RESULTS: Mean age was 58±11 years, 65% were women and 67% were black. VECAC ≤10, 11–400 and >400 AU was observed in 68%, 12% and 20% of subjects, respectively. Compared with VECAC ≤10, VECAC categories 11–400 (HR 2.25, 95% CI 1.24 to 4.08) and >400 AU (HR 3.05, 95% CI 1.87 to 4.98) were associated with the primary outcome after adjusting for traditional risk factors, MPI findings and CFR. Adding VECAC to a model that included PET–MPI, CFR and clinical risk factors improved the prognostic value for the primary outcomes (c-statistic 0.71 to 0.75 with VECAC, p=0.01). CONCLUSIONS: VECAC is a potent predictor of events beyond traditional risk factors and PET imaging markers, including CFR. These data further support the importance for routine VECAC implementation. BMJ Publishing Group 2021-05-07 /pmc/articles/PMC8108688/ /pubmed/33963079 http://dx.doi.org/10.1136/openhrt-2021-001648 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Cardiac Risk Factors and Prevention Selvaraj, Senthil Khan, Muhammad Shoaib Vidula, Mahesh K Wiener, Philip C de Feria, Alejandro E Rojulpote, Chaitanya Krishnan, Sheela Tamrat, Ruth Julien, Howard Jacoby, Douglas Litt, Harold Pryma, Daniel Dubroff, Jacob Guerraty, Marie A Bravo, Paco Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging |
title | Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging |
title_full | Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging |
title_fullStr | Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging |
title_full_unstemmed | Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging |
title_short | Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging |
title_sort | incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging |
topic | Cardiac Risk Factors and Prevention |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108688/ https://www.ncbi.nlm.nih.gov/pubmed/33963079 http://dx.doi.org/10.1136/openhrt-2021-001648 |
work_keys_str_mv | AT selvarajsenthil incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT khanmuhammadshoaib incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT vidulamaheshk incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT wienerphilipc incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT deferiaalejandroe incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT rojulpotechaitanya incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT krishnansheela incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT tamratruth incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT julienhoward incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT jacobydouglas incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT littharold incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT prymadaniel incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT dubroffjacob incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT guerratymariea incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging AT bravopaco incrementalprognosticvalueofvisuallyestimatedcoronaryarterycalciuminpatientsundergoingpositronemissiontomographyimaging |